COVID-2019 vaccine (OSE Immunotherapeutics)

N/A

Report date: 2024/11/24 20:00:04

Base Information

Drug NameCOVID-2019 vaccine (OSE Immunotherapeutics)
Drug Alias NameCoVepiTCoVepiT COVID-2019 vaccine (OSE Immunotherapeutics)COVID-19 prophylactic vaccine (OSE Immunotherapeutics)OSE13E
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOse Immunotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenexi SasOse Immunotherapeutics
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A